Silver Sulfadiazine and Recombinant Human Epidermal Growth Factor Treatment for Neonatal Extravasation
Patients receiving infusions with high extravasation risk should be continuously and carefully evaluated for signs of dislocation, leakage swelling, or extravasation to quickly identify and prevent further injury. Combining SSD and rh-EGF may be an alternative treatment for advanced extravasation lesions in the NICU.
Authors
- Chuan Nie (ORCID: https://orcid.org/0000-0003-4390-6008)
- Hang Lin (ORCID: https://orcid.org/0000-0002-0781-6630)
- Wen-Ji Zhou (ORCID: https://orcid.org/0000-0002-5116-5679)
- Xiaorui Huang (ORCID: https://orcid.org/0000-0003-2423-4939)
- Ying Zhang (ORCID: https://orcid.org/0000-0002-6296-8901)
Institutions
- Guangdong Province Women and Children Hospital (CN)
Publication Details
- Journal
- Advances in Neonatal Care
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1097/anc.0000000000001265
- Citations
- 1
- Primary Topic
- Chemotherapy-related skin toxicity
- Type
- article
- Field-Weighted Citation Impact
- 2.00